Compare VKTX & TAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VKTX | TAC |
|---|---|---|
| Founded | 2012 | 1909 |
| Country | United States | Canada |
| Employees | N/A | 1350 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.5B |
| IPO Year | 2014 | N/A |
| Metric | VKTX | TAC |
|---|---|---|
| Price | $32.87 | $12.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $94.44 | $23.67 |
| AVG Volume (30 Days) | ★ 2.1M | 855.7K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.96 | $8.34 |
| 52 Week High | $43.15 | $17.88 |
| Indicator | VKTX | TAC |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 42.39 |
| Support Level | $30.64 | $12.08 |
| Resistance Level | $35.85 | $12.78 |
| Average True Range (ATR) | 1.48 | 0.45 |
| MACD | -0.29 | -0.14 |
| Stochastic Oscillator | 21.33 | 22.41 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse electrical power generation assets in Canada, the United States, and Western Australia. The company has reportable segments namely, Hydro, Wind & Solar, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.